Tesla ( TSLA) was the best-performing stock in the S&P 500 as the feud between CEO Elon Musk and President Donald Trump that ...

U.S. equities rebounded from earlier losses when President Donald Trump said he and Chinese leader Xi Jinping would hold ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

This was the stock's second consecutive day of losses.

Humana Inc. closed 43.21% below its 52-week high of $406.46, which the company reached on July 18th.

On Wednesday, Cantor Fitzgerald analysts maintained their Neutral rating for Humana stock (NYSE: NYSE:HUM), keeping the price target steady at $290.00. The decision comes after an analysis of ...

Stock futures saw a slight uptick on Wednesday morning as investors monitored for potential discussions between President ...

Investing.com -- Health insurance company Humana (NYSE: HUM) has confirmed its full-year adjusted earnings per share (EPS) forecast. The company still anticipates an adjusted EPS of about $16.25 ...

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...